MARK G STRAUSS MD NPI 1629053186

NPI Details

Mark G Strauss, MD is an internal medicine in Corpus Christi, TX with 53 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Mark G Strauss, MD NPI is 1629053186. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Graduation Year:1972

The provider's business location address is:

7121 S PADRE ISLAND DR
STE. 300
CORPUS CHRISTI, TX
ZIP 78412-938
Phone: (361) 696-6200
Fax: (361) 696-6054

The NPI 1629053186 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Hemoglobin a1c level (HCPCS:83036)
• Ldl cholesterol level (HCPCS:83721)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Urine microalbumin (protein) level (HCPCS:82043)
• X-ray of chest, 2 views (HCPCS:71046)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Bacterial colony count, urine (HCPCS:87086)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Removal of impacted ear wax (HCPCS:69210)
• Ferritin (blood protein) level (HCPCS:82728)
• X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Ct scan of abdomen and pelvis before and after contrast (HCPCS:74178)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician (HCPCS:93015)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Vitamin d-3 level (HCPCS:82306)
• Folic acid level, serum (HCPCS:82746)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• Bacterial culture, any other source except urine, blood or stool, aerobic (HCPCS:87070)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 12/7/2005 and was last updated on 3/19/2014.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.